Julie Gerberding, EVP, Chief Patient Officer at Merck & Company, holds 48.71K shares in Merck & Company (Ticker: MRK), holds 15.03K shares in Cerner (Ticker: CERN), holds ― shares in HilleVax, Inc (Ticker: HLVX).

See the Hottest Stocks Based on Insider Trading >

Julie Gerberding
Merck & Company (MRK)
EVP, Chief Patient Officer

Ranked #62,070 out of 98,564 Corporate Insiders

Profitable Transactions

1 out of 4 Profitable Transactions

Average Return

-8.00%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

MRK

0.00%

HLVX

A breakdown of Julie Gerberding's holdings

See the Top Stocks by Insiders

Insider Roles

Merck & Company
(MRK)

EVP, Chief Patient Officer

HilleVax, Inc
(HLVX)

Director

Roles that Julie Gerberding holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Merck & Company
(MRK)

Rating:Informative Sell

Date:Nov 08, 2016 - Nov 08, 2017

Return:+3.70%

The most profitable trade made by Julie Gerberding

See the Latest Stocks Traded by Insiders

Julie Gerberding's Trading History

MRK

Merck & Company

Feb 28, 2022

EVP, Chief Patient Officer

Uninformative Buy

702.02K

$6.18M

CERN

Cerner

May 20, 2021

―

Uninformative Buy

―

$1.43M

HLVX

HilleVax, Inc

―

Director

―

List of latest transactions for each holding click on a transaction to see Julie Gerberding's performance on stock

See All Insider Trading from Today

Julie Gerberding insider profile FAQ

What is the percentage of profitable transactions made by Julie Gerberding?

The percentage of profitable transactions made by Julie Gerberding is 25%.

What is the average return per transaction made by Julie Gerberding?

The average return per transaction made by Julie Gerberding is -8.00%.

What stocks does Julie Gerberding hold?

Julie Gerberding holds: MRK, CERN, HLVX stocks.

What was Julie Gerberding’s latest transaction?

Julie Gerberding latest transaction was an Uninformative Buy of $702.02K.

What was Julie Gerberding's most profitable transaction?

Julie Gerberding’s most profitable transaction was an Informative Sell of MRK stock on November 8, 2016. The return on the trade was 3.70%.

What is Julie Gerberding's role in Merck & Company?

Julie Gerberding's role in Merck & Company is EVP, Chief Patient Officer.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Julie Gerberding Insider Profile

Julie Gerberding Merck & Company (MRK)EVP, Chief Patient Officer